Zobrazeno 1 - 10
of 44
pro vyhledávání: '"David Clever"'
Publikováno v:
Journal of Bone Oncology, Vol 45, Iss , Pp 100580- (2024)
Externí odkaz:
https://doaj.org/article/846ff49eca7740a39d53ddb2c4538cad
Autor:
Roberta Faccio, Cynthia X. Ma, Haley Ellis, Emily Eul, David Clever, Seunghyun Lee, Aude-Hélène Capietto
In vivo anti-Gr1 Ab treatment fails to deplete CD11b+/Gr1+ myeloid cells in bone marrow of mice with skeletal tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf99f95e5b350bae61b305972acdd1c
https://doi.org/10.1158/2326-6066.22544064
https://doi.org/10.1158/2326-6066.22544064
Autor:
Roberta Faccio, Cynthia X. Ma, Haley Ellis, Emily Eul, David Clever, Seunghyun Lee, Aude-Hélène Capietto
Osteoclast (OC) blockade has been successful in reducing tumor growth in bone in preclinical settings, but antiresorptive drugs, such as zoledronic acid (ZA), fail to improve the overall survival rate of patients with bone metastasis despite ameliora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f0ae6fd7ae5d50340420c4c2b5e34f
https://doi.org/10.1158/2326-6066.c.6550521
https://doi.org/10.1158/2326-6066.c.6550521
Autor:
Nicholas P. Restifo, Rahul Roychoudhuri, Marcus W. Bosenberg, Mark Raffeld, Chyi-Chia R. Lee, David F. Stroncek, Francesco Marincola, Ena Wang, Hui Liu, Luca Gattinoni, Zulmarie Franco, James J. Morrow, Madhusudhanan Sukumar, Joseph G. Crompton, Christopher A. Klebanoff, Gautam U. Mehta, Ian S. Goldlust, Ken-ichi Hanada, Alena Gros, Yun Ji, Holger Pflicke, Liqiang Xi, Douglas C. Palmer, Melody Roelke-Parker, Zhiya Yu, David Clever, Nicolas Acquavella
Fig. S1. Establishment of SB-3123 murine melanoma model. Fig. S2. Schematic of primer design for BRAF c.1799T > A (V600E) mutation analysis in SB-3123p murine melanoma cells. Fig. S3. SB-3123p melanoma is highly sensitive to vemurafenib. Fig. S4. BRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e2f934c744af33f0ef1e95415e86aa9
https://doi.org/10.1158/2326-6066.22537816.v1
https://doi.org/10.1158/2326-6066.22537816.v1
Autor:
Nicholas P. Restifo, Rahul Roychoudhuri, Marcus W. Bosenberg, Mark Raffeld, Chyi-Chia R. Lee, David F. Stroncek, Francesco Marincola, Ena Wang, Hui Liu, Luca Gattinoni, Zulmarie Franco, James J. Morrow, Madhusudhanan Sukumar, Joseph G. Crompton, Christopher A. Klebanoff, Gautam U. Mehta, Ian S. Goldlust, Ken-ichi Hanada, Alena Gros, Yun Ji, Holger Pflicke, Liqiang Xi, Douglas C. Palmer, Melody Roelke-Parker, Zhiya Yu, David Clever, Nicolas Acquavella
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7076632336db9a9696ef74b31c9c7d9c
https://doi.org/10.1158/2326-6066.22537813
https://doi.org/10.1158/2326-6066.22537813
Autor:
Nicholas P. Restifo, Douglas T. Fearon, Steven A. Rosenberg, Christopher A. Klebanoff, Mark S. Sundrud, Pawel Muranski, Luca Gattinoni, Francesco M. Marincola, Ena Wang, Nicolas Acquavella, Anthony Leonardi, Trevor Upham, Ryan D. Michalek, Sid P. Kerkar, Douglas C. Palmer, Zhiya Yu, Ken-ichi Hanada, Eric Tran, Robert L. Eil, Alena Gros, David Clever, Rahul Roychoudhuri, Madhusudhanan Sukumar, Joseph G. Crompton
Supplemental Figure S4. Akti-treated tumor-specific Pmel CD8+ T cell have reduced phosphorylation of Akt and substrates in presence of pharmacologic inhibition of Akt.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10bf35d07ce15c74ea0203064f3435e4
https://doi.org/10.1158/0008-5472.22408146.v1
https://doi.org/10.1158/0008-5472.22408146.v1
Autor:
Nicholas P. Restifo, Douglas T. Fearon, Steven A. Rosenberg, Christopher A. Klebanoff, Mark S. Sundrud, Pawel Muranski, Luca Gattinoni, Francesco M. Marincola, Ena Wang, Nicolas Acquavella, Anthony Leonardi, Trevor Upham, Ryan D. Michalek, Sid P. Kerkar, Douglas C. Palmer, Zhiya Yu, Ken-ichi Hanada, Eric Tran, Robert L. Eil, Alena Gros, David Clever, Rahul Roychoudhuri, Madhusudhanan Sukumar, Joseph G. Crompton
Adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) results in complete regression of advanced cancer in some patients, but the efficacy of this potentially curative therapy may be limited by poor persistence of TIL afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d30cf163157e16519ea315f366777c8
https://doi.org/10.1158/0008-5472.c.6507471.v1
https://doi.org/10.1158/0008-5472.c.6507471.v1
Autor:
Michelle Gosselin, Scott J. Luhmann, Kirsten Brouillet, Farshid Guilak, David Clever, Dominic Thompson
Publikováno v:
Journal of pediatric orthopedics. 41(10)
BACKGROUND In pediatric patients, the presentation of the nontraumatic acutely painful joint/limb poses a diagnostic dilemma due to the similarity of presentations of the most likely diagnoses [septic arthritis (SA), transient synovitis (TS), osteomy
Autor:
Aude-Hélène Capietto, Seunghyun Lee, Roberta Faccio, Haley Ellis, Emily Eul, David Clever, Cynthia X. Ma
Publikováno v:
Cancer Immunol Res
Osteoclast (OC) blockade has been successful in reducing tumor growth in bone in preclinical settings, but antiresorptive drugs, such as zoledronic acid (ZA), fail to improve the overall survival rate of patients with bone metastasis despite ameliora
Autor:
David Clever, Matthew L. Goodwin
Publikováno v:
Chordoma of the Spine ISBN: 9783030762001
Chordomas are locally aggressive, slow-growing tumors. Typically found in the axial skeleton, they are thought to be derived from notochord remnants. The notochord is a critical midline structure present in the early weeks of embryogenesis, where it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::826c6882aca3ec3be6b227bd9d7f5338
https://doi.org/10.1007/978-3-030-76201-8_1
https://doi.org/10.1007/978-3-030-76201-8_1